Glioma patients with high ETV5 or FBXW9 expression experienced worse survival than those with low expression (Fig. 5c), and high IGFBP5 expression in combination with high ETV5 or FBXW9 expression was significantly associated with the worst survival rate among all the groups (Fig. 5m). Here, IGFBP5 is linked to central nervous system cancer.